Value of postoperative adjuvant therapy in patients with completely resected stage Ⅱ or ⅢA non-small cell lung cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(2): 97-98. DOI: 10.3969/j.issn.1671-5144.2003.02.011
|
Citation:
|
Value of postoperative adjuvant therapy in patients with completely resected stage Ⅱ or ⅢA non-small cell lung cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(2): 97-98. DOI: 10.3969/j.issn.1671-5144.2003.02.011
|
Value of postoperative adjuvant therapy in patients with completely resected stage Ⅱ or ⅢA non-small cell lung cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(2): 97-98. DOI: 10.3969/j.issn.1671-5144.2003.02.011
|
Citation:
|
Value of postoperative adjuvant therapy in patients with completely resected stage Ⅱ or ⅢA non-small cell lung cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(2): 97-98. DOI: 10.3969/j.issn.1671-5144.2003.02.011
|
DownLoad: